Wes Streeting’s row with pharma firms grows as they reject NHS drug pricing offer
A row between Wes Streeting and pharmaceutical companies has intensified after drugmakers rejected the health secretary’s latest offer on NHS drug pricing,The two sides failed to reach agreement by a midday deadline on Friday, meaning the mechanism under which the health service claws back some of the money it pays for medicines will continue at a rate the industry said was “unsustainable” and could ultimately disadvantage patients,At the heart of the dispute is the voluntary scheme for branded medicines pricing, access and growth (VPAG), under which pharma companies agree the amount of revenues from drug sales to the NHS they have to pay back,The two sides have been in acrimonious negotiations for months after the government raised the rate last December unexpectedly to almost 23% for 2025 for newer medicines,It is understood that Streeting had made an ultimatum that if the industry did not accept his latest “generous” offer on pricing then the arrangement would continue unamended and on Friday that scenario came to pass.
According to the Financial Times, which first reported the health secretary’s letter to the APBI, his proposed offer included lower rebate rates in all future years of the scheme and an increase in the the price of new medicines and net spending on them,The industry body, the Association of the British Pharmaceutical Industry (ABPI), said the stalemate could mean companies launch fewer medicines in the UK, which could ultimately disadvantage patients,A government spokesperson said the clawback scheme “helps improve access to cutting-edge treatments for NHS patients while keeping the medicines bill sustainable for taxpayers”,They said it was “regrettable” that the ABPI did not want to take the government’s proposals to a board vote, adding: “We have therefore determined that the interests of patients and the NHS are best served by concluding the review and continuing with the existing VPAG scheme unamended, while continuing to support the UK’s world-leading life sciences sector,”The ABPI, which includes large drugs companies such as AstraZeneca, Pfizer and Roche, hit back, demanding “urgent action” from the government to address the issues affecting the sector.
It added that VPAG – which means drug companies are forced to pay between a quarter and a third of UK drug sales back to the NHS – was “undermining UK patient access to innovative medicines and the competitiveness of the UK life sciences industry”.Labour has identified life sciences as a key growth sector for the economy.Richard Torbett, the chief executive of the ABPI, said: “We need to reach a solution that improves patient access to future innovation, allows the sector to fulfil its growth potential, and does not require industry to pay back nearly three times as much of its revenues as is required in other European countries.”Sign up to Business TodayGet set for the working day – we'll point you to all the business news and analysis you need every morningafter newsletter promotionHe added: “Without change, the UK will continue to fall down international league tables for research, investment, and patient access to medicines.”The UK government’s latest offer had included lower rebate rates in all future years of the scheme, an average double-digit percentage increase in the price of new medicines to support wider patient access to a range of drugs, and a commitment to accelerating net spending on new medicines, with specific 10-year targets, according to people briefed on the contents.
Pharma companies have previously said the current 22.9% rebate, which marks a significant increase on the payment of about 5% of revenue paid in 2021 under a previous agreement, made “future UK investment … unlikely”.Pascal Soriot, the chief executive of AstraZeneca, said earlier this year that the new rate had discouraged investment in Britain, but claimed it did not have anything to do with the company’s decision in January to pull the plug on a £450m investment in its vaccines plant at Speke in Merseyside.The French pharma company Sanofi said the government’s proposal was “not good enough” and called on ministers to do more to “invest in innovation”.Johan Kahlström, the managing director of the drugmaker Novartis in UK and Ireland, said the lack of agreement between the sector and government was “a serious setback for UK patients, the NHS, and the life sciences sector”.
The NHS row comes as Donald Trump’s White House puts pressure on the industry internationally, threatening a crackdown on pharma firms unless they lower drug prices for Americans.In addition, the US president has vowed repeatedly to ramp up tariffs on imported drugs to sky-high levels, in an attempt to get companies to relocate production to the US.Earlier in the week, Eli Lilly, the US manufacturer of the weight-loss jab Mounjaro, said it was increasing the UK price by up to 170%, taking a month’s supply of the highest dose from £122 to £330.
England get the party started on a night that shows just how big this World Cup could be | Andy Bull
Electric atmosphere in Sunderland and at the stadium proves women’s tournament has grown up quicker than anyone ever expectedIt was quiet at Sunderland station on Friday afternoon, and quiet all the way up Union and South Streets and quiet all the way along to Keel Square, where the World Cup was hidden, waiting around the corner like a surprise party. There three, four, five thousand or more were bouncing up and down while a stout lad with Spandex trousers, a sequined jacket and serious pipes was belting out the opening notes of We Will Rock You on the big stage while his band thrashed away behind him. If everywhere else around town was empty, it was because everyone was here. It was a hell of a way to start a World Cup.“Let’s show them how we do it in the north-east!” shouted out the Mackem Mercury as he set a carnival parade off marching over the bridge towards the Stadium of Light for the kick-off
England off to a flyer in 11-try Women’s Rugby World Cup mauling of USA
Outside chatter of a Rugby World Cup favourites tag and expectations on a team can only go so far, the Red Roses had to go out and prove it on the pitch. The host nation more than lived up to their hype as they kicked off their campaign in front of a record crowd for an opening game at a women’s World Cup with a hugely dominant display against the USA which has underlined their ambitions for the World Cup crown.The prop Hannah Botterman and the centre Megan Jones were standouts in a good team display and the scary thought for their future opponents is that the performance was far from England’s best.Handling errors were at the heart of the sloppy areas for the Red Roses but the hosts were commanding at scrum time which got them out of jail on a few occasions. When their attack did click nothing could stop them, the best try of the 11 coming with Botterman’s clever line run in the first half
Aussie ace Asfoora earns tilt at Irish prize after blitzing Nunthorpe field
The third time was the charm for the Australian-trained sprinter Asfoora as Henry Dwyer’s mare took the Group One Nunthorpe Stakes, the feature on day three of the Ebor Festival, after near-misses at Royal Ascot and Glorious Goodwood. “It’d be a bad night to be a beer in York, I’d reckon,” Dwyer told ITV Racing, before heading to the winner’s enclosure to kick off the celebrations.Oisin Murphy enjoyed a perfect trip on the 11-1 shot, as he was able to slipstream Night Raider, the early pacesetter, through the first three-and-a-half furlongs and then quicken into a decisive lead when Danny Tudhope’s mount drifted right a furlong out. But while it was very much Plan A from the rider’s point of view, the dedication required to get Asfoora spot-on for this high-speed dash down the Knavesmire should not be underestimated.Her attempt to win the King Charles III Stakes at Royal Ascot in June for the second year running had ended in valiant defeat, while Asfoora was still not quite at her peak for the King George Stakes at Goodwood in August
Keegan Bradley agonising over whether to be a playing Ryder Cup captain for US
Keegan Bradley has opened up on the intense strain associated with his upcoming and “defining” decision on whether to play for, as well as captain, the United States in the Ryder Cup.“I am going to be really happy when this week is over,” Bradley said. “I have about had it with this whole thing. I am ready to figure out what we are doing and get a team together.”Bradley is due huge credit for his candour
Rugby World Cup: Ireland offer support to Shannon Ikahihifo after cancer diagnosis
Ireland’s World Cup squad have offered their support to their teammate Shannon Ikahihifo after she revealed her breast cancer diagnosis. The Trailfinders second-row Ikahihifo, who has three Irish caps, was part of the pre-tournament training group but did not make the final squad.On Friday the 30-year-old posted news of her condition on Instagram, writing: “Crazy to think that one day you can be running around on the rugby pitch feeling completely fine, then five days later you’re sitting in a hospital room being told you have cancer.“ Still a little in shock if I’m honest, but I’m so blessed to have the most amazing husband, family and friends that always carry when things start to feel a bit heavy. Fair to say she’s been a pretty tough few weeks
Serena Williams built her legacy on defiance. Why lend it to Ozempic culture? | Bryan Armen Graham
When Serena Williams was featured in a People magazine story on Thursday morning discussing her 31lb weight loss, the rollout had all the hallmarks of an advertisement draped in the thin veil of an all-caps EXCLUSIVE.Vogue’s social channels amplified their own access, NBC’s Today show gave her a one-on-one segment and Elle published a carefully packaged interview in which Williams declared she wanted to break the stigma around weight-loss drugs, each of them in lockstep with what appeared to be a hard 9am press embargo. This vintage Jill Smoller quadrafecta was not a spontaneous confessional; it was a coordinated media blitz pegged to the US Open, the tentpole event of American tennis, which kicks off on Sunday in earnest.Yet for all the precision and polish, it was unmistakably a commercial. The product wasn’t just Williams’s refined physique, already the subject of months-long speculation among her 32 million followers across social media
Why Shabana Mahmood’s outlook on prisons is wrong | Letter
Action to tackle number of asylum seekers coming to UK is important step to ‘restoring order’, says Cooper – as it happened
Stella Creasy and Richard Tice call for scrutiny over which EU laws UK ditches
Labour-run councils consider legal challenges to asylum hotels
How Labour can build a stronger British economy | Letters
Reeves leaves no stone unturned as she mulls reforms for property tax